A study by Aarnoutse et al. (2022) identified a significant reduction in species richness (p = 0.042) within the gut microbiomes of estrogen-receptor-positive BC patients undergoing treatment with (neo)adjuvant chemotherapy drugs [37]. Here, ESR1 is linked to breast cancer.